EoCyte markets and sells to Health Care Professionals, differentiating, innovating products and services of Personalized Medicine where Diagnostics and Treatments are adapted to everyone’s genetics. EoCyte started its activity with a range of 40 non invasive genetic tests, covering the main disorders in the field of Nutrigenomics as well as metabolic diseases (e.g. genetic or mitochondrial) Today EoCyte brings the pharmaceutical way of commercialization to the Diagnostic field within an attractive model for several players . As a consequence of its current activity , EoCyte builds a robust Rx platform and develops a new access to the attractive market of Personalized Medical and Wellness Care, for new products or services in this area. Based in Brazil, EoCyte focuses on the fast growing Latin American Market, and provides its out-licensing partners with unique, integrated commercial solutions.